LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...
AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...
Irish Independent on MSN2d
Flu is leading to school absences but uptake of vaccine low – survey revealsMore than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...
Canada has detected its first presumptive case of H5 bird flu in a person, a teenager in the western province of British ...
The Irish Patients Association is calling on parents and guardians of children to join together with them in ‘Flunion’ in the ...
Operator Good day, and welcome to the OPKO Health third quarter of 2024 financial results conference call. All participants ...
Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisor, ...
AstraZeneca’s new U.S. spending also leaves in doubt the pharmaceutical company’s plans to invest in a vaccine site in ...
Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...
Glamour on MSN1d
The RSV Vaccine for Infants: Everything Parents Need to KnowThe other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback